Back to P& PAULSON & CO. INC.

BHCBHC
Showing 8 of 27 quarters

Position history for P&PAULSON & CO. INC.'s holdings in Valeant Pharmaceuticals Intern

PAULSON & CO. INC. holds 73.3M shares of BHC (Valeant Pharmaceuticals Intern), worth $361.2M as of 2026-Q2. BHC represents 14.0% of PAULSON & CO. INC.'s portfolio.

Current Value

$361.2M

Current Shares

73.3M

Total Value Change

+$145.4M

Total Shares Change

+46.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
73.3M
0.0%
$361.2M14.0%$4.93
0
2026-Q1
Unchanged
73.3M
0.0%
$395.6M12.7%$5.73
0
2025-Q4
Increased
73.3M
+3.5%
$509.1M15.6%$6.99
66
2025-Q3
Increased
70.8M
+115.8%
$456.4M15.4%$6.47
100
2025-Q2
Increased
32.8M
+24.0%
$218.4M10.9%$6.46
75
2025-Q1
Unchanged
26.4M
0.0%
$171.1M9.8%$6.48
0
2024-Q4
Unchanged
26.4M
0.0%
$213.1M12.9%$7.73
0
2024-Q3
Unchanged
26.4M
0.0%
$215.7M15.1%$8.26
0

Other major holders of BHC: BNP PARIBAS FINANCIAL MARKETS, ICAHN CARL C

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used